Phreesia, Inc. (NYSE:PHR) Shares Sold by Lazard Asset Management LLC

Lazard Asset Management LLC trimmed its holdings in Phreesia, Inc. (NYSE:PHR - Free Report) by 35.1% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 42,977 shares of the company's stock after selling 23,267 shares during the period. Lazard Asset Management LLC owned 0.07% of Phreesia worth $1,081,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also recently added to or reduced their stakes in the company. Charles Schwab Investment Management Inc. grew its stake in Phreesia by 10.3% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 493,448 shares of the company's stock valued at $12,415,000 after acquiring an additional 46,209 shares during the last quarter. Wesbanco Bank Inc. grew its stake in Phreesia by 76.9% in the 4th quarter. Wesbanco Bank Inc. now owns 46,000 shares of the company's stock valued at $1,157,000 after acquiring an additional 20,000 shares during the last quarter. Barclays PLC grew its stake in Phreesia by 83.6% in the 3rd quarter. Barclays PLC now owns 94,929 shares of the company's stock valued at $2,163,000 after acquiring an additional 43,225 shares during the last quarter. Proficio Capital Partners LLC acquired a new stake in Phreesia in the 4th quarter valued at about $377,000. Finally, M&T Bank Corp grew its stake in Phreesia by 56.4% in the 4th quarter. M&T Bank Corp now owns 54,939 shares of the company's stock valued at $1,382,000 after acquiring an additional 19,812 shares during the last quarter. 92.10% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, SVP David Linetsky sold 4,499 shares of the stock in a transaction on Wednesday, April 16th. The shares were sold at an average price of $23.73, for a total value of $106,761.27. Following the completion of the sale, the senior vice president now owns 217,239 shares of the company's stock, valued at $5,155,081.47. This represents a 2.03% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, General Counsel Allison C. Hoffman sold 3,496 shares of the stock in a transaction on Monday, March 17th. The stock was sold at an average price of $25.32, for a total transaction of $88,518.72. Following the completion of the sale, the general counsel now directly owns 139,134 shares of the company's stock, valued at $3,522,872.88. The trade was a 2.45% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 42,474 shares of company stock valued at $1,023,208. Insiders own 5.80% of the company's stock.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on the stock. Piper Sandler reaffirmed an "overweight" rating and set a $33.00 price target (up from $31.00) on shares of Phreesia in a research note on Wednesday, January 29th. KeyCorp decreased their price target on shares of Phreesia from $30.00 to $28.00 and set an "overweight" rating on the stock in a research note on Wednesday, April 16th. DA Davidson decreased their price target on shares of Phreesia from $36.00 to $34.00 and set a "buy" rating on the stock in a research note on Monday, April 14th. Needham & Company LLC reaffirmed a "buy" rating and set a $29.00 price target on shares of Phreesia in a research note on Thursday, March 13th. Finally, Canaccord Genuity Group raised their price target on shares of Phreesia from $34.00 to $35.00 and gave the stock a "buy" rating in a research note on Thursday, March 13th. Twelve research analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, Phreesia currently has a consensus rating of "Buy" and an average target price of $31.33.

Phreesia Stock Performance

Shares of PHR stock opened at $25.36 on Tuesday. Phreesia, Inc. has a one year low of $17.07 and a one year high of $30.53. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.74 and a current ratio of 1.74. The company has a 50 day moving average price of $25.32 and a 200 day moving average price of $25.08. The firm has a market capitalization of $1.51 billion, a price-to-earnings ratio of -17.25 and a beta of 0.74.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.